ÎïÁªÍøÊ®ÄêÉú³¤£¬ÏÉÈË×îÏÈ´ò¶·£¬Ò»¶¨¡°ÂòÂòÂò¡± | AGÑÇÖÞÓÎÊÓ²ì
2020Äê4ÔÂ17ÈÕAGÑÇÖÞÓÎ×ÊÔ´ÈÙ»ñ2019ÄêÒ½ÁÆ¿µ½¡ÁìÓò²ÆÎñÕÕÁÏ»ú¹¹10Ç¿ | AGÑÇÖÞÓÎÐÂÎÅ
2020Äê4ÔÂ17ÈÕ
йڷÎÑ×ÒßÇ齫¶îÎÂǹ´ø½øÁ˸÷È˵ÄÉúÑÄ£¬ÌìÌì¡°°¤¼¸Ç¹¡±£¬¶Ô×Ô¼ººÍËûÈ˶¼ËãÈÏÕæ¡£¶îÎÂǹ³ÉΪÉçÇø±£°²µÄ±êÅ䣬¼Ì¿ÚÕÖ¡¢Ïû¶¾ÒºÖ®ºó£¬¶îÎÂǹҲ³ÉÁË¡°Ï¡È±ÎïÆ·¡±£¬ÔÀ´²»µ½Á½°Ù¿é¾ÍÄÜÂòµ½µÄ¶îÎÂǹÔÚµçÉÌƽ̨ҪÈý°Ù¡°ÆðÌø¡±¡£Ò»¡°Ç¹¡±ÄÑÇóµÄÊг¡ÉÏ£¬¼ÛÇ®ÒÑìÉýÁËÓâÊ®±¶¡£
¶îÎÂǹÊôÓÚµç×ÓÌåμƵÄÒ»ÖÖ£¬ µç×ÓÌåμÆÊÇɶ£¿Öйúµç×ÓÌåμÆÐÐÒµ×îÔçÆðÔ´ÓÚ1998Ä꣬ÒÔÿÄê¸ßÓÚ30%µÄËÙÂÊÉú³¤ÖÁ½ñÂÄÀúÁËÊ®¶àÄêʱ¼ä£¬ÍâÑó×ÅÃûÆ·ÅÆÓС°Å·Ä·Áú¡±¡¢¡°½ÝÍþ¡±µÈ£¬ º£ÄÚÒ²ÓÐÒ²ÓС°º£¶û¡±¡¢¡°±¶¶û¿µ¡±µÈÆ·ÅÆ¡£µç×ÓÌåμÆÓÉζȴ«¸ÐÆ÷£¬Òº¾§ÏÔʾÆ÷£¬Å¦¿Ûµç³Ø£¬×¨Óü¯³Éµç·¼°ÆäËûµç×ÓÔªÆ÷¼þ×é³É¡£ÄÜ¿ìËÙ׼ȷµØÕÉÁ¿ÈËÌåÌåΣ¬Óë¹Å°åµÄË®Òø²£Á§ÌåμÆÏà±È£¬¾ßÓжÁÊýÀû±ã£¬ÕÉÁ¿Ê±¼ä¶Ì£¬ÕÉÁ¿¾«¶È¸ß£¬ÄÜÓ°Ïó²¢ÓзäÃùÌáÐѵÄÓŵ㣬ÓÈÆäÊǵç×ÓÌåμƲ»º¬Ë®Òø£¬¶ÔÈËÌå¼°ÖÜΧÇéÐÎÎÞº¦£¬ÌØÊâÊʺÏÓÚ¼ÒÍ¥£¬Ò½ÔºµÈ³¡ºÏʹÓã¬Ëü²»ÊÇͨË׵ĵç×Ó²úÆ·¶øÊôÓÚ¶þÀà¼ÒÓÃÒ½ÁÆÆ÷е¡£
ÏÖÔÚ£¬ÎÒÃÇÈëÕýÌ⡣ʲôÊǼÒÍ¥Ò½ÁÆÆ÷еÊг¡£¿Æ¾Ö¤ÃÀ¹úThe National Academies of Science Engineering MedicineÎÄÏ×ÉϵĽç˵£¬¼ÒÍ¥Ò½ÁÆÆ÷е¿ÉÒÔ·ÖΪ12´óÀ࣬°üÀ¨£º
ÕâôÁÉÀ«µÄ½ç˵£¬±ÈÖйú¼ÒÍ¥Ò½ÁÆÊг¡ºÏ°üÀ¨µÄÖÖÀàËƺõ¸üΪÖÜÈ«¡£ÃÀ¹úµÄ¼ÒÍ¥Ò½ÁÆÊг¡¾ÓÉÁËÉú³ÝÀÏÁ仯֮ºóµÄ³¤×ãÉú³¤£¬¾ÝThe Centers for Medicare & Medicaid Servicesͳ¼Æ£¬ÃÀ¹ú2004ÄêÓп¿½ü830Íò½ÓÊÜÒ½ÁƽòÌù¼ÒÍ¥»¥Àû£¬¶ø1995Äê¸ÃÈËÊý²Å164Íò¡£
ͼƬȪԴ£ºThe Centers for Medicare & Medicaid Services
ҽԺʹÓÃÒ½ÁÆÆ÷еµÖ¼ÒÓÃÒ½ÁÆÆ÷еµÄ±äǨ£º×îÔçÆÚµÄʱ¼ä£¬ÃÀ¹ú³£¼ûµÄ¼ÒÍ¥Ò½ÁÆÆ÷еÀàËÆÓÚÓÚ¼ÆÁ¿±£¬Ìåμƣ¬ÂÖÒΣ¬ÖúÌýÆ÷µÈ¡£Øʺ󣬸ü¶àҽԺʹÓõÄÒ½ÁÆÆ÷е±»ÒýÈëµÖ¼ÒͥʹÓã¬×ÊÖú²¡È˸üÀû±ãºÍÈÝÒ×µÄÖÎÀí¿µ½¡£¬ÀàËÆÓÚѪѹ¼Æ¡¢ÑªÌÇÒǵȡ£ÕûÌå¶øÑÔµÄÇ÷ÊÆÊÇ£¬Ô½À´Ô½¶àÒÑÍù¿´ËÆרҵºÍÖØ´óÒ½ÓÃÆ÷е£¬¾ÓɸÄÁ¼ºÍµ÷½â±»ÒýÈë¼ÒÍ¥Ò½ÁÆÊг¡£¬Æä±³ºóµÄÇý¶¯Á¦ÊǸ߰ºµÄÒ½ÁÆ¿´»¤±¾Ç®¡¢Ò½»¤Ö°Ô±Ç·È±ÓëÉú³ÝÀÏÁ仯֮¼äµÄÖØ´óì¶Ü£¬ºÃ±ÈºôÎü»ú¡¢¼ÒÓÃ͸Îö»ú¡£×Ô1982Äê°Ä´óÀûÑÇϤÄá´óѧɳÀûÎĽÌÊÚ·¢Ã÷CPAP (Continuous Positive Airway PressureÒ»Á¬ÆøµÀÕýѹ)ÒÔÀ´£¬¼ÒÍ¥ÖÐʹÓÃÎÞ´´ºôÎü»úµÄÀíÄîÔÚÎ÷·½¹ú¼Ò»ñµÃ¿ìËÙÆÕ¼°¡£Öйú×Ô1992Äê×îÏÈÒý½øÎÞ´´ºôÎü»úÖÎÁÆ÷ýÖ¢¡¢ºôÎüÔÝÍ££¬2010ÄêÒÔºóÎÞ´´ºôÎü»ú×îÏÈÆÕ±éµØÓ¦ÓÃÓÚ¼ÒÍ¥ÖÎÁÆCOPD (Chronic Obstructive Pulmonary Disease ÂýÐÔÛÕ±ÕÐԷμ²²¡)¡¢Éñ¾¼¡Èⲡ±ä¡£
Ìáµ½ºôÎü»ú£¬²»µÃ²»ÌáÈ«ÇòºôÎü»ú¾ÞÍ·Èð˼Âõ£¨ResMed£©¡£Èð˼Âõ£¨ResMed£©È«Çò¼ÒÍ¥Ò½ÁÆÆ÷е¾ÞÍ·µÄÀ©ÕÅ£ºÊг¡»úÔµ¼ÓÉÏ×ÔÉíÄÜÁ¦µÄ»ýµí£¬ResMedµÄÉú³¤ËÙÂʾªÈË¡£ResMedÔÚ1990ÄêµÚÒ»¸ö²ÆÎñÄê¶ÈµÄÊÕÈë²»µ½100ÍòÃÀÔª£¬Ö»ÓÐ9ÃûÔ±¹¤¡£¶ø²»µ½30ÄêµÄʱ¼ä£¬ResMedÏÖÔÚÒѳÉΪһ¼ÒÊÐÖµÁè¼Ý150ÒÚÃÀÔª¡¢ÄêÊÕÈëÓâ20ÒÚÃÀÔªµÄ±êÆÕ500¹«Ë¾¡£2018²ÆÄ꣬ResMedÓªÒµÊÕÈë23.4ÒÚ£¬ÆäÖÐÑз¢ÓöÈ1.55ÒÚÃÀÔª£¬ÓªÒµÀûÈó5.3ÒÚÃÀÔª¡£
ͼƬȪԴ£ºDAS Capital Analysis
2019Ä꣬ResMedÒÔ2.25ÒÚÃÀÔªÊÕ¹ºÁËÊý×ÖÒ½Áƹ«Ë¾Propeller Health£¬Ö¼ÔÚͨ¹ýPropeller HealthÔÚÊý×ÖÊÖÒÕ·½ÃæµÄÓÅÊÆ£¬Ç¿»¯ResMedÏÖÓвúÆ·µÄ¹¦Ð§¡£ResMed½ü¼¸ÄêÊÕ¹º¹«Ë¾ºÍÐû²¼ÐÂÆ·µÄÐж¯¿ÉÒÔ¿´³ö£ºÔÚÊ×´´ÈËPeter FarrellÏòµ¼ÏµÄResMedÉî¸ûÓ²¼þ²úÆ·ÁìÓò¶àÄ꣬ÐÂÈÎCEO Mick Farrell½ÓÈκó£¬ÕýÔÚʵÑéת»»ÈüµÀ£¬ÒýÁìResMed½ø¾üÒ½ÁÆ×°±¸Êý×Ö»¯ÁìÓò¡£¾Ý²»Íêȫͳ¼Æ£¬½ö2015ÄêÖÁ½ñ£¬ResMed¾Í³â¾Þ×ÊÊÕ¹ºÁË12¼Ò¹«Ë¾£¬ÆäÖÐÓÐ9¼Ò¹«Ë¾ÓëÊý×Ö»¯Ð§ÀÍÈí¼þÓйء£Í¨¹ý¡°ÔÆÅþÁ¬£«Êý×Ö»¯¡±ÊÖÒÕ£¬ResMedÖ𽥴³öÒ»Ìס°Ó²¼þ£«Èí¼þ£«Ð§ÀÍ¡±µÄÉú̬¹¤ÒµÁ´¡£
ͼƬÌåÏÖ£º2015ÄêÖÁ½ñ£¬Èð˼ÂõÊÕ¹º¹«Ë¾µÄÇéÐÎÏÈÈÝ
»Ø¹éµ½º£ÄÚ£¬ÖйúÒѾÔÚ2015Äê³ÉΪ¼ÌÃÀ¹úÒÔºóµÄµÚ¶þ´óÈ«ÇòÒ½ÁÆÆ÷еÊг¡¡£
ÀÏÁ仯´ßÈÈ¡°Àà¼Òµç¡±Êг¡£º¾Ý¹ú¼Òͳ¼Æ¾ÖÊý¾ÝÏÔʾ£¬ÖÁ2016Äê⣬ÎÒ¹ú65ÖÜËê¼°ÒÔÉÏÉú³Ý´ï1.44ÒÚ£¬Õ¼×ÜÉú³ÝµÄ10.47%¡£Æ¾Ö¤ÍŽá¹úµÄ»®¶¨·²65ËêÒÔÉϵÄÍíÄêÉú³ÝÕ¼×ÜÉú³ÝµÄ±ÈÀý´ï7%ÒÔÉÏ»ò60ËêÒÔÉÏÍíÄêÉú³ÝÔÚ×ÜÉú³ÝÖеıÈÖØÁè¼Ý10%µÄ¼´ÊôÓÚÍíÄêÐ͹ú¼Ò»òµØÇø£¬ÎÒ¹úÔÚ2000ÄêʱÒѲ½ÈëÀÏÁ仯Éç»á¡£ÎÒ¹úÓëÈÕ±¾µÄÀÏÁ仯½Ú×àÊ®·ÖÏàËÆ£¬µ«ÎÒ¹úµÄÀÏÁ仯ËÙÂÊÏÔ×ÅÒª¿ìÓÚÈÕ±¾¡£±ÈÕÕÈÕ±¾Éú³ÝµÄÉú³¤¹ì¼£¿ÉÒÔ·¢Ã÷£¬ÎÒ¹úÏÖÔÚ15-64ËêµÄÉú³ÝÕ¼±ÈÒѾÁè¼ÝÈÕ±¾½ü50ÄêÀ´15-64ËêÉú³ÝÕ¼±ÈµÄ×î´óÖµ£¬ÒÔ´ËÀàÍÆ£¬ÎÒ¹úÔÚδÀ´20Ä꽫»á½øÈëÉú³ÝÀÏÁ仯µÄ¿ìËÙÉúÄ;㬶øµ½2050Äê×óÓÒ£¬ÖйúµÄÀÏÁ仯ˮƽ½«µÖ´ïÏÖÔÚÈÕ±¾µÄˮƽ¡£½ìʱ£¬ÎÒ¹úµÄÌÇÄò²¡¡¢¸ßѪѹ¡¢¸ßѪ֬¡¢ÐÄÄÔѪ¹ÜµÈÂýÐÔ¼²²¡Öð²½³ÉΪÍíÄêÉç»áµÄ½¹µã¿µ½¡ÎÊÌâ¡£
º£¶û¡¢»ªÎªµÈ¾ÞÍ·¶¼Ôڽṹ£ºº£¶ûÔڼҵ硢¼ÒÍ¥¿µ½¡Ò½ÁƵÈÁìÓòͬ²½·¢Á¦¡£ÔÚº£¶û¼ÒÍ¥Ò½Áƾ۽¹µÄºôÎüÀà(ÖÆÑõ»ú¡¢ºôÎü»ú¡¢Îí»¯Æ÷µÈ)ºÍÕÉÁ¿Àà(Ѫѹ¼Æ¡¢ÌåμƵÈ)²úÆ·ÖУ¬Ã¿Ò»Àà²úÆ·¶¼»á°Ñ¿µ½¡Êý¾Ý×öÒ»¸öÍøÂ磬һ·½ÃæÔÚºôÎü·½ÃæÌáÉýÓû§¿µ½¡Ë®Æ½£¬ÁíÒ»·½Ãæͨ¹ýÕÉÁ¿Àà²úÆ·¾ÛÊÊÓû§¿µ½¡Êý¾Ý¡£ÎÒÃÇÕýÔÚͨ¹ýÎïÁªÍøʵÏÖÊÖÒÕºÍģʽµÄÀå¸ï£¬Í¨¹ýÍÚ¾ò´óÊý¾ÝµÄ¹²ÏíÓ¦Óã¬Íƶ¯¸üÇå¾²¡¢±ã½ÝµÄÒ½ÁÆЧÀÍˮƽÌáÉý.ÏÖÔÚ£¬º£¶û¼ÒÍ¥Ò½ÁÆÒѾ¼Ü¹¹ÆðÒ½ÁÆÆ÷еºÍ´ó¿µ½¡Õչ˻¤Ê¿Á½´óÆ·À࣬°üÀ¨ÒÔÖÆÑõ»ú¡¢ÑªÑ¹¼Æ¡¢Îí»¯Æ÷¡¢Ìåμơ¢ºôÎü»ú¡¢ÑªÑõÒÇ×é³ÉµÄÒ½ÁÆÆ÷е²úÆ·;ÒÔÖÇÄÜ˯Ãß¡¢¿Ú±ÇÇ»Õչ˻¤Ê¿¡¢ÍÆÄÃÕչ˻¤Ê¿¡¢¿µ½¡ÀíÁÆ×é³ÉµÄ´ó¿µ½¡Õչ˻¤Ê¿²úÆ·¡£Óû§Í¨¹ýÖǼÒAPPÓëÖÇÄÜÒ½ÁÆÓ²¼þÅþÁ¬£¬¼´¿ÉÔÚ¼ÒÏíÊÜÒ½ÁÆÕչ˻¤Ê¿×ÔÖúʽ·þ
Îñ¡£¾Ý²ÆÁªÉçÐÂÎÅ£¬»ªÎªÆìÏÂÈ«×Ê×Ó¹«Ë¾¹þ²ª¿Æ¼¼Í¶×ÊÓÐÏÞ¹«Ë¾Í¶×ʵÄÉî˼Ë÷È˹¤ÖÇÄÜ»úеÈ˿Ƽ¼£¨±±¾©£©ÓÐÏÞ¹«Ë¾Ä±»®ÓªÒµ±¬·¢±ä»»£¬¹«Ë¾Ä±»®¹æÄ£ÐÂÔö¿µ½¡ÖÎÀí¡¢¿µ½¡×Éѯ£¨Ðè¾ÉóÅúµÄÕïÁÆÔ˶¯³ýÍ⣩¡£ÖµµÃ×¢ÖصÄÊÇ£¬ÏúÊÛÒ½ÁÆÆ÷еI¡¢IIÀà¡¢ÅÌËã»ú¡¢Èí¼þ¼°¸´ÖÆ×°±¸¡£×÷Ϊº£ÄڿƼ¼ÆóÒµµÄ´ú±í£¬»ªÎªÔçÒÑ×îÏÈÔÚÒ½ÁÆÁìÓò½á¹¹¡£ÌØÊâ×¢ÖصÄÊÇ£¬5GµÄµ½À´£¬½«¶ÔÒ½ÁÆÁìÓò±¬·¢²»Ð¡µÄÓ°Ïì¡£¾ÍÒÔÆ÷е¶øÑÔ£¬5GÊÖÒÕ»á¼ÓËÙÒ½ÁÆÆ÷еСÐÍ»¯¡¢ÖÇÄÜ»¯µÄÇ÷ÊÆ£¬ÈçÔ¶³Ì³¬ÉùºÍ³µÔØCTµÈ¡£Ëü¿ÉÒÔÖúÁ¦Ô¶³ÌÒ½ÁÆ£¬»º½âÒ½ÁÆ×ÊÔ´ÂþÑܲ»¾ùºÍ¿çµØÇø¾ÍÕïµÄÄÑÌ⡣ϸ·ÖÊг¡Ê±»ú£º³ýÁËѪÌÇÒǺͺôÎü»úÁ¿´ó×î¾ßDZÁ¦Æ·ÖÖ¼á³Ö¸ßËÙÔöÌíÍ⣬ÖÆÑõ»ú¡¢µç×ÓѪѹ¼Æ¡¢Îí»¯Æ÷µÈ½¹µã´óÆ·ÖÖÒ²¼á³Ö¿ìËÙÔöÌí¡£ÒÔÎí»¯Æ÷ΪÀý£¬Îí»¯ÎüÈëÆ÷Äܽ«Ò©ÒºÎí»¯³É¼«Ï¸Ð¡µÄÎíÁ££¬×÷ΪÆøÎí±»²¡ÈËÖ±½ÓÎüÈëÖÎÁÆ»òÓÃÓÚÍâò²¡ÔîÅçÒ©ÖÎÁÆ£¬ÊDZÇÑס¢ÑÊÑס¢¼±ÂýÐÔÖ§Æø¹ÜÑס¢·ÎÆøÖס¢Ïø´¡¢·Î²¿»òƤ·ôѬȾµÈÓÐÓõĸøÒ©ÒÇÆ÷¡£Îí»¯ÖÎÁÆÒ©Îï¿ÉÒÔÖ±´ï»¼²¡²¿Î»£¬Òò´ËÔÚºôÎü¿ÆÊÇÓ¦ÓýÏÁ¿ÆÕ±éµÄ£¬Òì±ûÍÐäå李¢²¼µØÄε¡¢ÁòËáɳ¶¡°·´¼¡¢ÒÒõ£°ëë×°±ËáÎüÈëÒºµÈÒ©Æ·¶¼Í¨¹ýÎí»¯ÎüÈë·½·¨¸øÒ©£¬ÔÚºôÎü¿Æ¾ßÓÐǿʢѧÊõʵÁ¦µÄ°¢Ë¹Àû¿µ¸üÊÇÒ»Á¬ÍƽøÓë´óÐÍÁ¬ËøÒ©µêÏàÖú½¨ÉèÎí»¯ÖÐÐÄ¡£
×ÛÉÏ£¬ÎÒÃÇÒÔΪÖйúµÄ¼ÒÓÃÒ½ÁÆÆ÷еÐÐÒµ¼´½«ÓÀ´ÁËÒ»¸öеÄÉú³¤½×¶Î£º1. ÖÇÄÜ»¯£ºÊÇÐí¶à²úÆ·Éý¼¶µÄÆ«Ïò£¬¼ÒÓÃÒ½ÁÆÆ÷еֻÊÇÆäÖÐÒ»¸ö·½Ã档δÀ´´ó²¿·ÖÒ½ÁÆÆ÷е½«¾ßÓÐÊý¾Ý¼Í¼¡¢´æ´¢¡¢´«ÊäµÈ¹¦Ð§£¬ÅäºÏÔ¶³ÌÒ½ÁƵÄÉú³¤£¬»¹»á·ºÆð´óÅúµÄ¿ÉÒÂ×ÅÒ½ÁÆÆ÷е£¬ÓÃÓÚÈËÌåÉúÃüÌåÕ÷µÄ¶¯Ì¬¼à²â£¬Ïà±ÈÆðÏÖÔÚÊÐÃæÉÏÄܹ»¿´µ½µÄһЩÔ˶¯¼à²â×°±¸£¬ÕÉÁ¿µÄÊý¾Ý½«Ô½·¢×¼È·£¬ÕÉÁ¿·½·¨Ò²Ô½·¢¿Æѧ¡£Î´À´µÄ¼à²â×°±¸»á½ÓÄɱê×¼»¯µÄÉú²ú·½·¨£¬°ü¹ÜÊý¾Ý׼ȷÐÔ£¬²¢ÇÒ½ÓÄÉÄܹ»ÓëÍøÂç×°±¸´®ÁªµÄ·½·¨£¬³ÉΪԶ³ÌÒ½ÁƺͼÒÍ¥Ò½ÁÆʵÏÖµÄÒ»¸ö»·½Ú¡£2. Ìñ¾²»¯£ºÈËÃǹØÓÚÒ½ÁÆ¿µ½¡µÄµÚÒ»¿´·¨ÊDz»Ìñ¾²µÄ£¬²»¹ÜÊÇÈ¥Ò½Ôº¿´²¡ÕվɽÓÊÜÖÎÁÆ£¬Õû¸öÀú³ÌÖÐ×ÜÊdzäÂúÁËÖÖÖֵIJ»ÊÊ£¬Ëæ׿ÒÍ¥Ò½ÁÆÕâ¸ö¿´·¨µÄÖð½¥ÊµÑ飬δÀ´µÄ¼ÒÍ¥Ò½ÁÆÆ÷е½«Ô½·¢×¢ÖØÌñ¾²»¯µÄʹÓ÷½·¨¡£¼ÒÍ¥ÊÇÒ»¸öÐÝÏ¢µÄµØ·½£¬ÔÚÕâÀïÆÕ±é»áÔ½·¢ÓÐÇå¾²¸Ð£¬ÒÔÊǹØÓÚÕâÀïʹÓõÄÆ÷еҲ½«Ìá³öÌñ¾²¶ÈµÄÒªÇó¡£